Michael Szelke
-
- Neuropeptides and Animal Physiology 10
- Molecular Biology top 10%
- Chemical Synthesis and Analysis 15
- Receptor Mechanisms and Signaling 8
- Protein Hydrolysis and Bioactive Peptides 5
- Biotechnology top 10%
-
- Renin-Angiotensin System Studies 15
-
- Peptidase Inhibition and Analysis 9
-
- Coagulation, Bradykinin, Polyphosphates, and Angioedema 6
-
- Helicobacter pylori-related gastroenterology studies 4
Michael Szelke
61 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 95
- Cellular and Molecular Neuroscience 230
- Molecular Biology 764
- Endocrinology, Diabetes and Metabolism 166
- Biotechnology 86
- Cardiology and Cardiovascular Medicine 226
Countries citing papers authored by Michael Szelke
This map shows the geographic impact of Michael Szelke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Szelke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Szelke more than expected).
Fields of papers citing papers by Michael Szelke
This network shows the impact of papers produced by Michael Szelke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Szelke. The network helps show where Michael Szelke may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Michael Szelke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 8 | |
| 2 | 1997 | 10 | |
| 3 | 1997 | 8 | |
| 4 | 1996 | 16 | |
| 5 | 1996 | 16 | |
| 6 | 1995 | 10 | |
| 7 | 1994 | 34 | |
| 8 | 1993 | 16 | |
| 9 | Severe hypotension with bradycardia during renin inhibition with H142 in sodium deplete man. | 1989 | 2 |
| 10 | 1989 | 1 | |
| 11 | 1988 | 14 | |
| 12 | 1987 | 82 | |
| 13 | 1987 | 5 | |
| 14 | 1987 | 5 | |
| 15 | Renin inhibitors: their use in understanding the role of angiotensin II as a pressor hormone. | 1985 | 4 |
| 16 | 1985 | 42 | |
| 17 | Peptide inhibitors of renin. | 1984 | 7 |
| 18 | H-77: a potent new renin inhibitor. In vitro and in vivo studies. | 1982 | 37 |
| 19 | 1982 | 183 | |
| 20 | 1970 | 8 |
About Michael Szelke
Michael Szelke is a scholar working on Structural Biology, Cardiology and Cardiovascular Medicine, Toxicology, Genetics and Cellular and Molecular Neuroscience, having authored 62 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chemical Synthesis and Analysis (15 papers), Renin-Angiotensin System Studies (15 papers), Neuropeptides and Animal Physiology (10 papers), Peptidase Inhibition and Analysis (9 papers), Receptor Mechanisms and Signaling (8 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Protein Hydrolysis and Bioactive Peptides (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). The work is most often cited by research in Cellular and Molecular Neuroscience (230 citations), Molecular Biology (764 citations), Endocrinology, Diabetes and Metabolism (166 citations), Biotechnology (86 citations) and Cardiology and Cardiovascular Medicine (226 citations). Michael Szelke has collaborated with scholars based in United Kingdom, Switzerland and United States. Frequent co-authors include Butrus Atrash, B Leckie, Dylan M. Jones, A. Hallett, Anthony F. Lever, D. Michael Jones, J.B. Cooper, J.E. Sueiras, T.L. Blundell and Hamish Ryder. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Hypertension, Nature, Journal of Cardiovascular Pharmacology and Biochemical Society Transactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.